|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.12 USD | -0.16% |
|
+6.22% | +8.39% |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| 06-10 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 33.3 | +74.18% | 12 | ||||||
| 833.31 | +27.36% | 28 | ||||||
| 287.95 | +10.96% | 19 | ||||||
| 2,056,533.8 | +44.72% | 24 | ||||||
| 96.61 | +14.36% | 16 | ||||||
| 220.28 | +1.93% | 31 | ||||||
| 45.85 | -42.52% | 20 | ||||||
| 111.27 | -4.78% | 22 | ||||||
| 101.58 | +33.59% | 26 | ||||||
| 481.25 | +0.47% | 12 | ||||||
| 102.28 | +32.5% | 23 | ||||||
| 276.47 | +13.16% | 21 | ||||||
| 458,000 | +34.11% | 5 | ||||||
| 87.85 | +48.92% | 26 | ||||||
| 349.78 | -6.74% | 9 | ||||||
| - | - | 61.5 | +1.28% | 1 | ||||
| 14.4 | +59.63% | 12 | ||||||
| 30.05 | +77.51% | 9 | ||||||
| 74.1 | -25.33% | 10 | ||||||
| 72.5 | +18.87% | 2 | ||||||
| Average | 125,890.71 | +20.71% | 16 | ||||||
| Weighted average by Cap. | 220,411.02 | +15.78% | 21 |
- Stock Market
- Stocks
- ZLAB Stock
- Sector Zai Lab Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
